Your session is about to expire
← Back to Search
Convalescent Plasma for Coronavirus
Study Summary
This trial will provide convalescent plasma to pediatric patients with underlying conditions who have either been infected with SARS-CoV-2 or been exposed to it. The plasma comes from people who have recovered from the infection. The trial will collect data on the safety and how well the plasma works.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant, breastfeeding, or planning to during the study.I have been in close contact with someone who has COVID-19.I am under 18 years old.You have tested positive for the SARS-CoV-2 virus or have been in close contact with someone who has the virus and is considered high-risk.I have had severe allergic reactions to blood transfusions.I am not pregnant, as confirmed by a test.
- Group 1: anti-SARS-CoV-2 human convalescent plasma
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Have researchers conducted any additional investigations using human convalescent plasma to combat SARS-CoV-2?
"Currently, there are 4 ongoing medical experiments investigating the potential of anti-SARS-CoV-2 human convalescent plasma and none have reached Phase 3. These trials mainly take place in Bonheiden, Brabant Wallon although a total of 21 locations host related studies."
Has the FDA officially given its stamp of approval for anti-SARS-CoV-2 human convalescent plasma?
"Our in-house experts have assigned anti-SARS-CoV-2 human convalescent plasma a score of 1 as this is still an early stage trial, meaning there are limited data to demonstrate safety and efficacy."
Does this trial have any age restrictions for participants?
"This investigation is seeking out participants aged between one month and 17 years."
Are there any available appointments for this research program?
"Unfortunately, this clinical trial is currently not accepting any new patients. The original posting of the study was on August 1st 2020 and there were no updates since July 7th 2020. For those looking for alternate studies to join, 91 trials are searching for participants with virus-related illnesses while 4 other studies are utilizing anti-SARS-CoV-2 human convalescent plasma and actively admitting patients."
To what capacity is this clinical trial accepting participants?
"Unfortunately, this particular study is not presently open for patient recruitment. It was originally published on August 1st 2020 and the last update to its information occurred in July of 2020. For potential participants searching for other medical studies, there are currently 91 clinical trials regarding viral diseases that are accepting candidates as well as 4 anti-SARS-CoV-2 human convalescent plasma experiments actively enrolling individuals."
Is it feasible for me to join this experiment?
"To be eligible for inclusion, potential candidates must suffer from a viral illness and lie between 1 Month and 17 years of age. A total of 30 people are being accepted into the trial."
Share this study with friends
Copy Link
Messenger